Quantification of Antidepressant and Antipsychotic Exposure Increase Caused by CYP2C19 and CYP2D6 Intermediate and Poor Metabolizer Status
Authorized Users Only
2019
Authors
Milosavljević, FilipBukvić, Nikola
Pešić, Vesna
Pavlović, Zorana
Miljević, Čedo
Molden, Espen
Ingelman-Sundberg, Magnus
Jukić, Marin
Conference object (Published version)
Metadata
Show full item recordKeywords:
Antidepressant / Antipsychotic / Pharmacokinetics / Pharmacogenetics / Precision Medicine Neuropsychiatric DiseasesSource:
Neuropsychopharmacology, 2019, 44, 139-Publisher:
- Springer Nature
Note:
- ACNP 58th Annual Meeting: Poster Session
DOI: 10.1038/s41386-019-0545-y
ISSN: 0893-133X
PubMed: 31801976
WoS: 000509665600273
[ Google Scholar ]Collections
Institution/Community
PharmacyTY - CONF AU - Milosavljević, Filip AU - Bukvić, Nikola AU - Pešić, Vesna AU - Pavlović, Zorana AU - Miljević, Čedo AU - Molden, Espen AU - Ingelman-Sundberg, Magnus AU - Jukić, Marin PY - 2019 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4752 PB - Springer Nature C3 - Neuropsychopharmacology T1 - Quantification of Antidepressant and Antipsychotic Exposure Increase Caused by CYP2C19 and CYP2D6 Intermediate and Poor Metabolizer Status IS - 44 SP - 139 DO - 10.1038/s41386-019-0545-y ER -
@conference{ author = "Milosavljević, Filip and Bukvić, Nikola and Pešić, Vesna and Pavlović, Zorana and Miljević, Čedo and Molden, Espen and Ingelman-Sundberg, Magnus and Jukić, Marin", year = "2019", publisher = "Springer Nature", journal = "Neuropsychopharmacology", title = "Quantification of Antidepressant and Antipsychotic Exposure Increase Caused by CYP2C19 and CYP2D6 Intermediate and Poor Metabolizer Status", number = "44", pages = "139", doi = "10.1038/s41386-019-0545-y" }
Milosavljević, F., Bukvić, N., Pešić, V., Pavlović, Z., Miljević, Č., Molden, E., Ingelman-Sundberg, M.,& Jukić, M.. (2019). Quantification of Antidepressant and Antipsychotic Exposure Increase Caused by CYP2C19 and CYP2D6 Intermediate and Poor Metabolizer Status. in Neuropsychopharmacology Springer Nature.(44), 139. https://doi.org/10.1038/s41386-019-0545-y
Milosavljević F, Bukvić N, Pešić V, Pavlović Z, Miljević Č, Molden E, Ingelman-Sundberg M, Jukić M. Quantification of Antidepressant and Antipsychotic Exposure Increase Caused by CYP2C19 and CYP2D6 Intermediate and Poor Metabolizer Status. in Neuropsychopharmacology. 2019;(44):139. doi:10.1038/s41386-019-0545-y .
Milosavljević, Filip, Bukvić, Nikola, Pešić, Vesna, Pavlović, Zorana, Miljević, Čedo, Molden, Espen, Ingelman-Sundberg, Magnus, Jukić, Marin, "Quantification of Antidepressant and Antipsychotic Exposure Increase Caused by CYP2C19 and CYP2D6 Intermediate and Poor Metabolizer Status" in Neuropsychopharmacology, no. 44 (2019):139, https://doi.org/10.1038/s41386-019-0545-y . .